Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

NCT00005796 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Bone Marrow Suppression
Brain and Central Nervous System Tumors
Drug/Agent Toxicity by Tissue/Organ

Interventions

PROCEDURE: filgrastim
BIOLOGICAL: gene therapy
DRUG: lomustine
DRUG: procarbazine hydrochloride
DRUG: vincristine sulfate
PROCEDURE: in vitro-treated peripheral blood stem cell transplantation

Sponsor

Indiana University